Boehringer Ingelheim Press Releases

Quick access for journalists to the latest press releases that cover corporate, research & development, prescription, industrial, animal health and consumer pharmaceutical news.

Information for

General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers

PRESS RELEASE

Press Release Overview

Here you can find an overview list of our recent Press Releases.

Read more
PRESS RELEASE 3 hrs ago

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center

Read moreon
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
- European Metacam® indication expanded to guinea pigs
PRESS RELEASE 18 Jun 2018 at 10:00

Boosting animal welfare for small animals: Boehringer Ingelheim expands European Metacam^® indication to guinea pigs

Read moreon
Boosting animal welfare for small animals: Boehringer Ingelheim expands European Metacam^® indication to guinea pigs
PRESS RELEASE 17 May 2018 at 09:00

Boehringer Ingelheim Expert Forum on Farm Animal Well-Being 2018

Read moreon
Boehringer Ingelheim Expert Forum on Farm Animal Well-Being 2018
PRESS RELEASE 15 May 2018 at 12:00

Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Center

Read moreon
Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Center
PRESS RELEASE 25 Apr 2018 at 13:30

Boehringer Ingelheim R&D pushes to transcend disease boundaries

Read moreon
Boehringer Ingelheim R&D pushes to transcend disease boundaries
PRESS RELEASE 25 Apr 2018 at 10:30

Boehringer Ingelheim has a very successful 2017 financial year

Read moreon
Boehringer Ingelheim has a very successful 2017 financial year
PRESS RELEASE 11 Apr 2018 at 14:00

Investment of 65 million euro in avian vaccines in France

Read moreon
Investment of 65 million euro in avian vaccines in France
- Cancer Immunology Innovation Approach
PRESS RELEASE 04 Apr 2018 at 18:00

New Immuno-Oncology Partnership with OSE Immunotherapeutics to Develop a Pioneering Checkpoint Inhibitor

Read moreon
New Immuno-Oncology Partnership with OSE Immunotherapeutics to Develop a Pioneering Checkpoint Inhibitor
PRESS RELEASE 28 Mar 2018 at 10:00

Boehringer Ingelheim announces 2018 BVDzero Case Awards

Read moreon
Boehringer Ingelheim announces 2018 BVDzero Case Awards
PRESS RELEASE 26 Mar 2018 at 10:00

Three leading animal health companies join hands to launch world-class vaccine joint venture targeting foot-and-mouth disease in China

Read moreon
Three leading animal health companies join hands to launch world-class vaccine joint venture targeting foot-and-mouth disease in China
PRESS RELEASE 19 Mar 2018 at 12:55

FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease

Read moreon
FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease
PRESS RELEASE 13 Mar 2018 at 14:00

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Read moreon
Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer
PRESS RELEASE 21 Feb 2018 at 10:00

2018 European PRRS Research Award open for submissions until July 1^st

Read moreon
2018 European PRRS Research Award open for submissions until July 1^st
- Primary_Portrait_Anna .jpg
PRESS RELEASE 16 Feb 2018 at 10:00

Systemic Sclerosis World Congress: Inspirational patient stories reveal the challenging realities of living with devastating rare disease

Read moreon
Systemic Sclerosis World Congress: Inspirational patient stories reveal the challenging realities of living with devastating rare disease
PRESS RELEASE 09 Feb 2018 at 12:00

Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer’s trials

Read moreon
Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer’s trials
PRESS RELEASE 15 Jan 2018 at 10:00

2018 'Ruminant Well-Being Awards’ open for application

Read moreon
2018 'Ruminant Well-Being Awards’ open for application
PRESS RELEASE 09 Jan 2018 at 15:00

BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab

Read moreon
BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab
- BI more than doubles the funding for its venture fund BIVF
PRESS RELEASE 03 Jan 2018 at 14:00

Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€

Read moreon
Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€
PRESS RELEASE 19 Dec 2017 at 10:00

Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases

Read moreon
Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases